YELENA KAJDIC: Open Payments
NPI 1154800308 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$574 in 21 payments from 10 companies in 2025. Trend: 2023 $261 · 2024 $359 · 2025 $574
Food & beverage: $574
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 7 | $218 |
| Regeneron Healthcare Solutions, Inc. | 3 | $156 |
| Optinose US, Inc. | 2 | $51 |
| Hikma Pharmaceuticals USA | 2 | $36 |
| Medtronic, Inc. | 1 | $23 |
| Olympus America Inc. | 1 | $23 |
| Stryker Corporation | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 2 | $18 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| Smith+Nephew, Inc. | 1 | $14 |
Products named: DUPIXENT, Xhance, Ryaltris, PROPEL, AUDION ET DILATION SYSTEM, VOQUEZNA, NUCALA, TULA.
Industry payments across FL — which companies pay providers there.
